登录新浪财经APP 搜索【信披】查看更多考评等级 本年度公司现金分红总额53,812,057.90元；本年度以现金为对价，采用集中竞价方式已实施的股份回购 金额75,864,030.95元，现金分红和回购金额合计129,676,088.85元，占本年度归属于上市公司股东净利润 的比例136.39%。其中，以现金为对价，采用要约方式、集中竞价方式回购股份并注销的回购（以下简 称回购并注销）金额0元，现金分红和回购并注销金额合计53,812,057.90元，占本年度归属于上市公司 股东净利润的比例56.60%。 如在本公告披露之日起至实施权益分派股权登记日期间，因可转债转股/回购股份/股权激励授予股份回 购注销/重大资产重组股份回购注销等致使公司总股本发生变动的，公司拟维持每股分配比例不变，相 应调整分配总额。如后续总股本发生变化，将另行公告具体调整情况。 本次利润分配方案尚需提交股东大会审议。 （二）是否可能触及其他风险警示情形 公司上市已满三个完整会计年度，本年度净利润为正值且母公司报表年度末未分配利润为正值，公司不 触及其他风险警示情形，具体如下： ■ 二、公司履行的决策程序 （一）董事会会议的召开、审议和 ...

Core Viewpoint - The company has approved a proposal to engage in foreign exchange hedging activities to mitigate risks associated with currency fluctuations as its overseas business grows [1][2]. Group 1: Foreign Exchange Hedging Activities - The company plans to conduct foreign exchange hedging activities, including but not limited to forward foreign exchange contracts, foreign exchange swaps, foreign exchange options, and other foreign exchange derivatives, with a maximum contract amount of up to 10 million USD or equivalent foreign currency [1]. - The authorization for these activities is valid for 12 months from the date of the board's approval, allowing for the funds to be used in a rolling manner within the specified limit [1]. - The board has authorized the general manager to approve daily foreign exchange hedging plans and sign related contracts, with the finance department responsible for the operation and management of these activities [1]. Group 2: Risk Management and Internal Controls - The foreign exchange hedging activities will primarily involve standard forward foreign exchange products and foreign exchange swaps, limited to the main settlement currencies used in the company's operations [2]. - The maximum delivery period for these hedging activities is generally not to exceed 12 months, and the funding for these activities will come from the company's own funds [2]. - The company has implemented strict internal review and risk control measures, including managing accounts receivable actively to prevent delays in delivery for forward foreign exchange contracts [2]. Group 3: Board Approval - The proposal was approved by the company's third board meeting with 7 votes in favor, 0 against, and 0 abstentions, and does not require submission to the shareholders' meeting for further approval [2]. - Relevant documents include the resolution of the third board meeting and the decision from the first special meeting of independent directors in 2025 [2].

Core Viewpoint - The company reported a decline in revenue and net profit for the year 2024, primarily due to falling prices of pesticide products, despite an increase in production and sales volume [18]. Group 1: Company Overview - The company, Haier Pharmaceutical Group Co., Ltd., is engaged in the research, production, and sales of pesticide formulations, intermediates, and raw materials, with a focus on insecticides and fungicides [4][15]. - The pesticide industry is characterized by relatively inelastic demand, playing a crucial role in agricultural production and food security [2][3]. Group 2: Financial Performance - The company achieved operating revenue of CNY 3.91 billion in 2024, a decrease of 11.16% from CNY 4.40 billion in 2023 [18]. - The net profit attributable to shareholders was CNY 181.37 million, down 61.67% from CNY 473.20 million in the previous year [18]. - The net cash flow from operating activities was CNY 285.55 million, a significant decrease of 70.11% compared to CNY 955.35 million in 2023 [18]. Group 3: Market Dynamics - The global demand for pesticides is expected to grow due to increasing food security needs and agricultural efficiency [2]. - China's pesticide production capacity is shifting towards countries like China and India, driven by the expiration of patents and restructuring by multinational agrochemical giants [2][3]. Group 4: Product Development - The company has been diversifying its pesticide offerings, with several new products entering trial production in recent years, including various insecticides and fungicides [4][5]. - The company is focusing on high-efficiency, low-toxicity pesticides to meet the growing market demand [2][4]. Group 5: Industry Trends - The pesticide industry is experiencing a shift towards biopesticides and environmentally friendly products, with increasing market share for biological and chemical pesticides [7]. - The market for generic pesticides is expected to expand as patents expire, providing opportunities for companies with strong R&D capabilities [2][3].

Group 1 - The company approved the proposal to reappoint Lixin as the auditor for the 2025 financial report and internal control audit [1][2] - The decision was made unanimously by the board with 8 votes in favor and no opposition [2] - The reappointment is subject to approval at the 2024 annual general meeting [2][6] Group 2 - The company announced a profit distribution plan for 2024, proposing a cash dividend of 2.0 yuan per 10 shares, totaling approximately 28.37 million yuan [4][5] - The net profit attributable to shareholders for 2024 is reported at approximately 90.18 million yuan, with distributable profits at approximately 280.52 million yuan [3][4] - The proposed cash dividend represents 42.56% of the net profit attributable to the parent company [5] Group 3 - The company plans to conduct foreign exchange hedging activities to mitigate risks associated with currency fluctuations, with a maximum amount of 300 million yuan or equivalent in foreign currency [10][12] - The hedging activities will involve major currencies such as USD and EUR, using methods like forward contracts and options [15][19] - The board approved the hedging proposal without requiring shareholder approval [20] Group 4 - The company provided a guarantee of 70 million yuan for its wholly-owned subsidiary, Wenzhou Weigang International Trade Co., Ltd., to support its bank credit needs [30][31] - The guarantee is valid for 12 months and can be reused within the approved limit [30][31] - The total amount of guarantees provided by the company is 70 million yuan, which accounts for 6.11% of the latest audited net assets [34] Group 5 - The company announced adjustments to the construction content of its fundraising project for a new production line, maintaining the total investment amount [35][45] - The project aims to enhance resource efficiency and ensure smooth implementation, with expected annual output value of approximately 79.24 million yuan [41][45] - The adjustments were approved by both the board and the supervisory committee and will be submitted for shareholder approval [46][48]

■ 除上述条款修订及条款序号同步更新外，《公司章程》其他内容不变。 浙能电力《股东会议事规则》修订对比表 ■ 除上述条款修订及条款序号同步更新外，《股东会议事规则》其他内容不变。 浙能电力《董事会议事规则》修订对比表 ■ 证券代码：600023 证券简称：浙能电力 公告编号：2025-008 浙江浙能电力股份有限公司 第五届监事会第四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 （一）浙江浙能电力股份有限公司（以下简称"公司"）第五届监事会第四次会议的召开符合《公司 法》、《公司章程》及有关法律、法规、规范性文件的规定，会议合法有效。 （二）本次会议通知于2025年4月17日以书面形式发出。 （三）本次会议于2025年4月27日在公司本部以现场结合通讯表决方式召开。 2.审议通过《2024年度财务决算报告》 表决情况：3票同意，0票反对，0票弃权 本议案需提交公司股东大会审议。 3.审议通过《2025年度财务预算报告》 表决情况：3票同意，0票反对，0票弃权 （四）会议应出席监事3人， ...

Group 1 - The company raised a total of RMB 1,026.87 million through a non-public offering of 99.89 million shares at a price of RMB 10.28 per share, with net proceeds amounting to RMB 1,014.40 million after deducting fees [2][3] - The company has established a dedicated account for the management of raised funds, signing tripartite and quadripartite supervision agreements with relevant banks and sponsors to ensure proper fund usage [3][4] - As of December 31, 2024, the company maintained one dedicated account for the raised funds [4] Group 2 - The company reported that the actual use of raised funds has been delayed for several projects, including the "Pharmaceutical Comprehensive R&D Center" and "Environmental Facility Renovation Project," due to strategic adjustments and external factors [5][6] - The "Pharmaceutical Comprehensive R&D Center" project was transferred to a subsidiary, and the implementation location was changed, leading to delays in investment progress [5][6] - The company stated that the benefits of certain projects cannot be individually accounted for, as their effectiveness is reflected indirectly through product quality improvements [7][10] Group 3 - The company reported a net loss of RMB 330.27 million for the year 2024, with total revenue of RMB 1,938.47 million [24][28] - The company proposed not to distribute cash dividends for 2024 due to the reported losses, aligning with its dividend policy [28] - The company has established a robust internal control system, ensuring compliance with relevant laws and regulations [31]

2025年4月29日消息，苏州科恩新能科技股份有限公司于 2025 年 4 月 28 日召开第一届董事会第七次会 议，审议通过了《关于公司开展外汇套期保值业务的议案》，该议案尚需通过股东大会的批准。 近年来，公司出口业务稳步增长，近期外汇汇率波动幅度较大，汇兑损益将对公司经营业绩产生影响。 为防范外汇风险、提高应对汇率波动能力、规避不良影响和提高外汇资金使用效率，公司拟开展外汇套 期保值业务。 外汇套期保值交易品种包括远期结售汇、外汇互换、外汇掉期、外汇期货、外汇期权、利率互换、利率 掉期、利率期权及其他金融衍生产品等业务或业务的组合，交易对方为具有合法经营资质的银行等金融 机构。资金规模合计不超过 200 万美元（或其他等值外币），在 12 个月内可循环使用，资金来源为自 有资金。实施方式为由公司董事会授权董事长审批日常方案及相关合同并负责决策、签署协议等事项。 套期保值交易有效期自 2024 年年度股东大会审议通过之日起至 2025 年度股东大会召开之日止。外汇套 期保值业务存在汇率波动、内部控制、履约、法律等风险。公司将密切关注市场动态，设定合理止损点 和止盈点，严格控制资金规模，设立计算机系统及相关设 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 公司及全资子公司拟向金融机构（包括银行、经国家金融监督管理总局批准设立的非银行金融机构）申 请合计不超过人民币35亿元的综合授信额度，融资方式包括但不限于贷款、银行保函或备用信用证、贸 易信用证、贴现、透支、汇票承兑、汇票保证、应收/应付账款融资、进口/出口融资等，具体以与银行 签署的协议为准。 为保障公司子公司日常经营需要的融资正常开展，公司为唯捷精测、上海唯捷、深圳唯捷在上述融资协 议额度项下提供必要担保，担保金额不超过人民币30,000万元，该担保金额可在上述子公司之间调剂使 用，担保方式为保证担保。 （二）内部决策程序 该事项已经公司第四届董事会第十三次会议审议通过，根据《上海证券交易所科创板股票上市规则》和 《公司章程》的有关规定，本担保事项经公司董事会审议通过后生效。 二、被担保人的基本情况 （一）被担保人一： 1、被担保人名称：北京唯捷创芯精测科技有限责任公司 2、成立日期：2020年1月19日 3、注册地址：北京市北京经济技术开发区科谷四街1号院16号楼 4、法定代表人：周颖 5、注册资本：20,000万元人民币 6、经营范围：半导体集成电路、 ...

Core Points - The company has guaranteed the authenticity, accuracy, and completeness of the information disclosed in its quarterly report [2][9] - The first quarter report for 2025 was not audited [3][7] - The company plans to apply for a comprehensive credit limit of up to RMB 2 billion to support its operational financing needs [9][10] - The company intends to use idle funds for entrusted wealth management, with an investment limit of up to RMB 300 million [11][56] - The board approved various financial and operational proposals, including foreign exchange derivative trading and hedging [16][18][41] Financial Data - The company reported that there are no adjustments or restatements required for previous accounting data [3][4] - The first quarter report reflects the actual operational situation without any significant omissions or misleading statements [9][38] - The company has provided guarantees for loans to its subsidiary, totaling RMB 250,000 [5][6] Shareholder Information - The company has disclosed the total number of shareholders and the shareholding structure of the top ten shareholders [5] - The company plans to hold its annual general meeting on May 15, 2025 [34] Other Important Matters - The company has approved the leasing of idle properties, with a total area of up to 33,574 square meters [21][45] - The board has agreed to repurchase and cancel 61,000 restricted shares due to the departure of an incentive object [24][47] - The company has established a plan for stock option price adjustments based on the profit distribution proposal [30][50]

Core Viewpoint - The company reported a significant decline in net profit for 2024, with a net loss of approximately 15.46 million yuan, a decrease of 129.60% compared to the previous year, despite a 51.95% increase in total revenue to approximately 1.36 billion yuan [27]. Company Overview - The company specializes in the research, production, and sales of semiconductor display devices and special adhesive materials, with key products including polarizers, functional devices, signal connectors, liquid crystal panels, and production auxiliary materials [3][9]. - The company has established strong partnerships with leading display panel manufacturers such as BOE, Huaxing Optoelectronics, and Foxconn, supplying products for well-known consumer electronics brands like Huawei, Xiaomi, and Apple [3][8]. Business Environment - A new round of government subsidies for replacing old televisions in mainland China is expected to stimulate demand in the television market, with subsidies ranging from 15% to 20% based on energy efficiency ratings [3]. - The global LCD TV panel shipment volume is projected to increase by approximately 9.3% year-on-year in Q4 2024, despite a 0.5% decline in Q3 2024, indicating a stabilizing effect from the subsidy policy [3][4]. Financial Performance - The company achieved total revenue of approximately 1.36 billion yuan in 2024, marking a 51.95% increase year-on-year, but reported an operating loss of approximately 26.02 million yuan, a decline of 147.65% compared to the previous year [27]. - Research and development expenses increased by 41.92% to approximately 55.28 million yuan, reflecting the company's commitment to innovation despite financial challenges [27]. Market Trends - The global display panel sales are expected to grow by 13% in 2024, driven by a recovery in demand across various end applications, particularly in the TV segment [4]. - The average size of global TV panels is projected to continue increasing, reaching 51.5 inches in 2024, with significant growth in the large and ultra-large size segments [7]. Production and Sales Model - The company primarily operates under a self-production model, supplemented by commissioned processing, allowing for flexibility and efficiency in meeting customer orders [23][24]. - The sales strategy focuses on direct sales, with the sales department responsible for customer development and maintaining relationships to ensure a steady flow of orders [25][26].